Metabolic & Fat Loss · Research Use Only
GLP-2 TZ
Also known as: Dual GIP/GLP-1 receptor agonist
GLP-2 TZ is a dual-incretin research peptide studied for agonism at both the GIP and GLP-1 receptors — the dual-agonist (tirzepatide-class) mechanism used in metabolic research.
View GLP-2 TZ product →What is GLP-2 TZ?
GLP-2 TZ is our designation for a dual-incretin research peptide that acts as an agonist at two receptors at once: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1. This dual-agonist approach is the tirzepatide-class mechanism studied in metabolic research.
How dual-incretin peptides are studied
In preclinical research, dual GIP/GLP-1 receptor agonists are investigated for how simultaneous activity at two incretin receptors affects signaling and metabolic markers in laboratory and animal models, compared with single-receptor agonists.
Handling, reconstitution & storage
Supplied lyophilized, stored at -20°C protected from light. Reconstituted with bacteriostatic or sterile water for research, then held at 4°C short-term or aliquoted at -80°C. An HPLC certificate of analysis accompanies each lot.
Frequently asked questions
What receptors does GLP-2 TZ act on?
It is a dual agonist at the GIP and GLP-1 incretin receptors — the tirzepatide-class mechanism studied in metabolic research.
How does GLP-2 TZ differ from a GLP-1 agonist like Semaglutide?
Semaglutide targets the GLP-1 receptor alone; GLP-2 TZ is a dual agonist that also targets the GIP receptor. Researchers compare single- vs multi-receptor agonism in metabolic models.
References
Related research peptides
Shop research-grade GLP-2 TZ, HPLC-tested with a COA on every batch.
View GLP-2 TZ →All information here is provided for laboratory and research reference only. Products are sold strictly for in-vitro research and development and are not for human or veterinary use.